Maryland, D.C., and Virginia — one of the largest life science corridors in the U.S.
Explore →
Philadelphia, South Jersey, and Delaware — a powerhouse of pharma and biotech innovation.
Explore →
North Carolina's Research Triangle — a growing hub for biotech and life sciences.
Explore →
Xcellon Biologics, a Maryland CRDMO specializing in bioconjugates and complex biologics, has signed a definitive agreement to acquire the GMP biologics manufacturing facility built by NextCure, Inc. in Beltsville. The deal gives Xcellon its first cGMP capacity, completes the company’s transition from a development-stage CDMO into an end-to-end CRDMO, and puts a commissioned domestic bioconjugation […]
Read More →BC3 Technologies, a Baltimore-based medical technology company focused on hemorrhage control, announced on September 10, 2026 that its SEAL Hemostatic Wound Spray is now stocked at 77 Army & Air Force Exchange Service (AAFES) locations across the U.S. and overseas, marking the company’s first expansion into brick-and-mortar retail. CEO and Co-Founder Wayne Grube called the […]
Each week, our Regional Roundup delivers the most important and timely life sciences news from around the region. From groundbreaking research to fundraising, new development projects, and who’s hiring — we bring you the top stories that matter most. Stay informed with a curated selection of the latest news, delivered directly to your inbox weekly. […]
GeneDx, the Gaithersburg, Maryland-based rare disease genomics company, and Beren Therapeutics P.B.C. announced on September 9, 2026 the launch of NPC GenomeComplete, a sponsored testing program offering no-cost comprehensive genome sequencing to eligible pediatric patients suspected of having Niemann-Pick Disease Type C (NPC). Lisa Gurry, Chief Business Officer at GeneDx, said: “For children with suspected […]
In biotech, pharma, medical devices, diagnostics, healthtech and more Maryland’s life sciences ecosystem is among the strongest in the nation, anchored by federal agencies like the NIH and FDA, world-class research institutions, and top universities that provide a deep pipeline of talent. Strong government support, active investment, and a growing network of industry leaders have […]
Every student in Frederick County, starting as early as sixth grade, now has access to a dedicated Career Coach whose job is to help them figure out what comes next. The Career Coach Program is a direct product of the Blueprint for Maryland’s Future, the state’s landmark education reform effort, and runs as a partnership […]
Sernova Biotherapeutics and Seraxis Holdings announced on September 8, 2026 that they’ve signed a definitive agreement to merge into a single company, BetaNova Biotherapeutics, combining two different pieces of the same puzzle: an implantable device that houses insulin-producing cells, and the stem-cell-derived islet cells meant to go inside it. The combined company will be headquartered […]
United Therapeutics Corporation, dual-headquartered in Silver Spring, Maryland and Research Triangle Park, North Carolina, announced on September 8, 2026 that it will use the remainder of its previously authorized $2 billion share repurchase program, entering an accelerated share repurchase (ASR) agreement with Citibank, N.A. to buy back approximately $477.6 million in common stock. Chairperson and […]
ARPA-H announced on September 9, 2026 the launch of ADVOCATE (Agentic AI-EnableD CardioVascular CAre TransfOrmation), a competitive awards program aimed at building what the agency calls the world’s first FDA-authorized clinical AI system for cardiovascular care, backed by up to $33.7 million in Year 1 of a four-year, $62.7 million program. ADVOCATE Program Manager Dr. […]
Quoin Pharmaceuticals, a Virginia-based specialty pharma company focused on rare and orphan diseases, announced on September 8, 2026 that the FDA has granted Rare Pediatric Disease designation to its lead drug candidate, QRX003, for Peeling Skin Syndrome — a rare inherited disorder that causes the skin’s outer layer to shed excessively, often leaving patients with […]
